Clinical Trial Update: Evaluation of 4th Generation Bipolar Radiofrequency Endometrial Ablation Device [Phase 4]

View source ↗

Summary

An update on a Phase 4 clinical trial evaluating a 4th generation bipolar radiofrequency endometrial ablation device for heavy menstrual bleeding.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menorrhagia

Drugs mentioned

• 4th Generation Bipolar Radiofrequency Endometrial Ablation Device

Snippet

Sponsor: Birmingham Women's NHS Foundation Trust | Conditions: Heavy Menstrual Bleeding | Phase 4 | Status: UNKNOWN